Yunnan Baiyao (000538)(000538)
Yunnan Baiyao Group Co., Ltd. is a company mainly engaged in chemical raw materials, chemical preparations, Chinese patent medicines, Chinese herbal medicines and biological products. The company's products are mainly Yunnan Baiyao series, Sanqi series and Yunnan national characteristic drugs series, with more than 200 products in *** 17 dosage forms. The products sell well in the domestic market and Southeast Asia, and gradually enter the markets of developed countries such as Japan, Europe and America. The company is one of the well-known Chinese patent medicine manufacturers in China, one of the large industrial and commercial pharmaceutical enterprises in Yunnan, and one of the top 50 Chinese patent medicines in China. 1997 was identified as one of the first batch of 40 large enterprises and groups in Yunnan province. Yunnan Baiyao ranked first among the top ten brands of traditional Chinese medicine enterprises in the list of top ten enterprises in various fields of Chinese medicine industry released for the first time by the brand selection activity of 20 10 brand summit of Chinese medicine industry. 20 17 September, Yunnan Baiyao was selected into the "20 16" published by China Pharmaceutical (600056) Industrial Information Center. ...
Chengzhi shares (000990)(000990)
The main business of Chengzhi Co., Ltd. includes the comprehensive operation of industrial gas and basic chemical raw materials, the production and sales of semiconductor display materials, the production and sales of life science and technology products and the cultivation, research and processing of industrial hemp and the sales of its products. The main products and services provided by the company include CO, hydrogen and syngas, ethylene, propylene, butanol, octanol and isobutyraldehyde, TN,STN and other monochromatic liquid crystal materials, TFT-LCD liquid crystal materials and OLED materials, D- ribose, L- glutamine, industrial hemp, and medical services such as diagnosis and treatment. As the only enterprise with complete intellectual property rights of D- ribose in the world, Chengzhi Bioengineering, a subsidiary company, passed the audit of strength certifiable company and obtained the AA certificate of BRCGS, which is the second time since 2020. Chengzhi Yonghua, a subsidiary of the company, is a high-tech enterprise, a state-level enterprise technology center, and a China optical photoelectric subsidiary. ...
Angel Yeast (600298)(600298)
Angel Yeast Co., Ltd. is engaged in the development, production and management of yeast, yeast derivatives and related biological products. The company's main products include: yeast and deep-processed products, health food, special nutritious food, baking raw materials, food additives, dairy products, condiments and so on. The company has formed a multi-service brand framework system, implemented brand segmentation in different professional fields, and built the strength of Angel brand cluster. Anqi brand has become an international brand with high popularity and wide influence. It is one of the top ten international registered enterprises in Madrid, China, with two well-known trademarks of China, Anqi and Fubang. "Angel" was selected as one of the top 100 most valuable brands in China, and "Angel Newt" was selected as one of the "Top 10 Credibility Brands of Health Products in China" for five consecutive years. The company was awarded "Top 100 Enterprises in Light Industry in China", "Top 10 Enterprises in Fermentation Industry in China", "Top 0 Listed Companies on Main Board in China 100", "Top 500 Listed Companies in China" and "The Best" ...
Asia Pacific Pharmacy (002370)(002370)
Zhejiang Yatai Pharmaceutical Co., Ltd. is mainly engaged in pharmaceutical manufacturing business, including research and development, production and sales of chemical preparations and chemical raw materials. The company's main products include anti-amoxicillin potassium clavulanate dispersible tablets, azithromycin dispersible tablets, azithromycin for injection, roxithromycin capsules and ceftizoxime sodium for injection. Roxithromycin capsules, cefalexin capsules, azithromycin dispersible tablets and azithromycin for injection are the leading products of our company. In 2007, the output of roxithromycin capsules ranked first in China, the output of cefalexin capsules ranked fourth in China and the output of azithromycin dispersible tablets ranked second in China.
Tasly (600535)(600535)
The main business of Tasly Pharmaceutical Group Co., Ltd. is the research and development, production and sales of drugs. The company's products mainly include Compound Danshen Dripping Pills, Yangxue Qingnao Granules, Yiqifumai for injection (freeze-dried), Tiqing, ShuiJia Lin and other drugs.
Origen (00270 1)
Origen (00270 1) Technology Co., Ltd. mainly provides comprehensive packaging solutions for all kinds of FMCG customers. The main products of the company are metal packaging products and services.
Shuanglu Pharmacy (002038)(002038)
Beijing Shuanglu Pharmaceutical Co., Ltd. mainly focuses on the research, development, production and operation of genetic engineering and related drugs, and closely focuses on the change of disease spectrum. The main products include recombinant human granulocyte stimulating factor, recombinant human interleukin -2, recombinant human interleukin-1 1, recombinant human basic fibroblast growth factor, temozolomide, arsenic trioxide, lenalidomide, complex coenzyme, thymopentin, enoxaparin sodium, loratadine dispersible tablets, telmisartan, docetaxel and adefovir dipivoxil. The company was selected as one of the key high-tech enterprises in the National Torch Plan, the first batch of "100 Innovative Enterprises" in Haidian Park of Zhongguancun (00093 1) Science Park, the "Beijing Biomedical Industry Leap-forward Development Project" (G20 Project) and the first batch of "100 Thousand Projects" in Zhongguancun National Independent Innovation Demonstration Zone. 20 10-20 1 1 was rated as the most competitive for two consecutive years. ...
Kang Enbei (600572)(600572)
The main business of Zhejiang Kangenbei Pharmaceutical Co., Ltd. is the research and development, manufacture, wholesale and distribution of drugs and health products. The company's main products are Qianliekang brand Pulean tablets and capsules, Tianbaoning brand Ginkgo biloba preparation, Kangenbei brand Changyanning, Jin Aokang brand omeprazole products, Jindi brand compound Houttuynia mixture, Zhenshiming brand eye drops and eye health products, Jin Aikang brand tetrandrine and Jin Kang Suli brand acetylcysteine. The company has been awarded the national innovative enterprise, the national modern industrial base of traditional Chinese medicine, the national recognized enterprise technology center and the national Post-Doctoral Research Center, and has established the Zhejiang Provincial Key Laboratory of Pharmaceutical Technology of Traditional Chinese Medicine, the Zhejiang Provincial Key Enterprise Research Institute and the Zhejiang Modern Botanical Medicine High-tech Research and Development Center.
Zixin Pharmaceutical (002118) (002118)
The main business of Jilin Zixin Pharmaceutical Co., Ltd. is Chinese patent medicine industry, ginseng industry and industrial hemp industry. The company's main products are pills, tablets, hard capsules, oral liquids, granules, oral solutions, mixtures, soft capsules, lozenges, ginseng products and industrial hemp products. The company's "Zixin" trademarks are well-known trademarks in China and Jilin Province. The company was rated as "Quality Unit in China Pharmaceutical Industry" and "Best Reputation Unit in Jilin Province"; "No fake units in China pharmaceutical industry"; "AAA China Credit Enterprise".
Harbin Pharmaceutical Co., Ltd. (600664)(600664)
Harbin Pharmaceutical Group Co., Ltd. focuses on the medical and health industry, mainly engaged in pharmaceutical R&D and manufacturing, wholesale and retail business, and is a large domestic high-tech pharmaceutical enterprise integrating pharmaceutical R&D, manufacturing and sales. The company's main products are anti-virus, anti-infection, cold medicine, cardiovascular and cerebrovascular diseases, digestive system, anti-tumor and nutritional supplements. At present, the company owns five well-known trademarks, including Harbin Pharmaceutical, Sanjing, Shiyitang, Gaizhonggai and Hutong, and the right to use Shiyitang 1 Chinese time-honored brand. Accumulated "China 100 Most Valuable Consumer Brand", "Self-owned Brand Enterprise with the Most Growth Force in the Industry", "Top Ten Brands in the International Market of China Industry", "Export Famous Brand of Heilongjiang Province", "Brand China Golden Spectrum Award-Top Ten Brands of the Year in China Pharmaceutical Industry", "Public Welfare Brand Award Influencing China", "Industry Leader Brand of China" and "Top Ten Innovative Brands in China Industry". ...